Ping Fang
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
-
- Circular RNAs in diseases 4
- Peroxisome Proliferator-Activated Receptors 3
-
- Lung Cancer Treatments and Mutations 8
-
- Gastrointestinal motility and disorders 3
-
- Drug Transport and Resistance Mechanisms 3
-
- Analytical Chemistry and Chromatography 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ping Fang
51 papers receiving 751 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 200
- Pharmacology 90
- Molecular Biology 341
- Pulmonary and Respiratory Medicine 153
- Biochemistry 33
Countries citing papers authored by Ping Fang
This map shows the geographic impact of Ping Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Fang more than expected).
Fields of papers citing papers by Ping Fang
This network shows the impact of papers produced by Ping Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Fang. The network helps show where Ping Fang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ping Fang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 28 | |
| 5 | 2020 | 24 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 13 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 5 | |
| 10 | 2017 | 13 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 38 | |
| 13 | 2017 | 21 | |
| 14 | 2016 | 32 | |
| 15 | 2016 | 12 | |
| 16 | 2015 | 68 | |
| 17 | 2015 | 34 | |
| 18 | 2014 | 22 | |
| 19 | [Clinical paired study of comparing docetaxel plus capecitabine versus docetaxel plus epirubicin as first-line treatment in women with HER-2 negative advanced breast cancer]. | 2013 | 4 |
| 20 | 2005 | 3 |
About Ping Fang
Ping Fang is a scholar working on Biological Psychiatry, Pharmacology and Gastroenterology, having authored 55 papers that have together received 755 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), Circular RNAs in diseases (4 papers), Gastrointestinal motility and disorders (3 papers), MicroRNA in disease regulation (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Cancer Research (200 citations), Pharmacology (90 citations) and Molecular Biology (341 citations). Ping Fang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hongyang Shi, Xiuzhen Sun, Manxiang Li, Dexin Zhang, Yun Liu, Yuqiang Ji, Guoxin Hu, Zheng Xiang, Jing Xu and Wei Li. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.